Security key
984015602
Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO)
CUSIP: 984015602
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 16,935
- Total 13F value
- $60,671
- Share change
- -353
- SEC-reported price per share
- $3.45
- Number of holders
- 7
- Value change
- -$1,088
- Number of buys
- 2
- Number of sells
- 3
- Shares outstanding
- 2,304,382
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q4 2023
Institutions
7
Top holders
7
XBIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Xenetic Biosciences, Inc. SEC filings
Xenetic Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 984015602
Recent filing periods:
Ownership snapshot
Top reported holders of XBIO - Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GEODE CAPITAL MANAGEMENT,...
Disclosed value leader
GEODE CAPITAL MANAGEMENT,...
Comparable rows
7/12
Latest evidence
11 Dec 2023
13F
3/4/5
Lead comparable stake: 0.48%
5 rows are not safely comparable across share classes.
Showing 1-6 of 12 holder rows.
Quick read
GEODE CAPITAL MANAGEMENT, LLC leads the comparable SEC ownership view at 0.48%.
7 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
GEODE CAPITAL MANAGEMENT, LLC
0.48%
JTC Employer Solutions Trustee Ltd
0.12%
Steward Partners Investment Advis...
0.08%
Tower Research Capital LLC (TRC)
0.06%
MORGAN STANLEY
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.48%
|
$53,813
10,998 shares
|
— | 30 Sep 2023 |
| JTC Employer Solutions Trustee Ltd |
13F
Company
|
0.12%
|
$8,000
2,700 shares
|
— | 30 Sep 2023 |
| Steward Partners Investment Advisory, LLC |
13F
Company
|
0.08%
|
$9,310
1,900 shares
|
— | 30 Sep 2023 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.06%
|
$6,782
1,384 shares
|
— | 30 Sep 2023 |
| MORGAN STANLEY |
13F
Company
|
0.01%
|
$1,446
295 shares
|
— | 30 Sep 2023 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
0%
|
$49
10 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
16,935
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
7
Q4 2023 holders
7
Holder diff
0
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend